Skip to main content

Want a detailed portfolio tracker?

Agilent Technologies (A) Total Debt (2006 - 2026)

Agilent Technologies (A) total debt from Oct 31, 2006 to Jan 31, 2026. The current Agilent Technologies (A) total debt is $5.91B. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Total Debt

Total Debt

Agilent Technologies (A) Total Debt CAGR table

PeriodCAGR
1 Year TTM+10.19%
3 Years TTM+3.78%
5 Years TTM+4.72%
10 Years TTM+6.25%

Annual Total Debt change of Agilent Technologies (A)

YearTotal DebtChange
2025$5.99B
+0.64%
2024$5.95B
+20.94%
2023$4.92B
-5.91%
2022$5.23B
-1.67%
2021$5.32B
+11.82%
2020$4.75B
+1.06%
2019$4.70B
+18.76%
2018$3.96B
-0.23%
2018$3.97B
+10.55%
2017$3.59B
+1.21%
2016$3.55B
+7.22%
2015$3.31B
-39.96%
2014$5.51B
+2.11%
2013$5.40B
+0.86%
2012$5.35B
+12.87%
2011$4.74B
-26.61%
2010$6.46B
+26.72%
2009$5.10B
+14.61%
2008$4.45B
N/A
2007$0
N/A
2006$0
N/A

Comparison Agilent Technologies (A) total debt with competitors

Agilent Technologies (A) total debt is $5.91B.

TickerNameTotal DebtUpside
ADVBAdvanced Biomed Inc$1.44M-99.98%
NDRAENDRA Life Sciences Inc$1.65M-99.97%
MBAICheckCap Ltd$1.83M-99.97%
CHEKCheck-Cap Ltd$1.83M-99.97%
APDNApplied Dna Sciences Inc$2.95M-99.95%
MYNZMainz Biomed N.V.$3.13M-99.95%
BIAFBioAffinity Technologies Inc$4.28M-99.93%
ISPCiSpecimen Inc$6.44M-99.89%
PRPOPrecipio Inc$6.64M-99.89%
XWELXWELL Inc$14.91M-99.75%
PREPrenetics Global Ltd - Class A$29.01M-99.51%
XGNExagen Inc$37.52M-99.36%
IMDXInsight Molecular Diagnostics Inc$51.12M-99.13%
FONRFonar Corp$54.77M-99.07%
PRPHProPhase Labs Inc$58.84M-99.00%
PSNLPersonalis Inc$70.63M-98.80%
BDSXBiodesix Inc$85.50M-98.55%
CSTLCastle Biosciences Inc$86.39M-98.54%
VCYTVeracyte Inc$91.99M-98.44%
CDNACaredx Inc$97.53M-98.35%
FLGTFulgent Genetics Inc$112.22M-98.10%
MDXHMDxHealth SA$160.05M-97.29%
BLLNBilliontoone Inc - Class A$195.11M-96.70%
TWSTTwist Bioscience Corp$221.12M-96.26%
WGSGeneDx Holdings Corp - Class A$252.18M-95.73%
ADPTAdaptive Biotechnologies Corp$281.70M-95.23%
GRALGRAIL Inc$302.79M-94.87%
BNRBurning Rock Biotech Ltd$304.48M-94.84%
MYGNMyriad Genetics Inc$336.30M-94.30%
NEONeogenomics Inc$523.27M-91.14%
NOTVInotiv Inc$625.32M-89.41%
OPKOpko Health Inc$652.19M-88.96%
NTRANatera Inc$840.38M-85.77%
MEDPMedpace Holdings Inc$1.53B-74.07%
IDXXIdexx Laboratories Inc$1.83B-69.02%
GHGuardant Health Inc$2.10B-64.50%
RDNTRadnet Inc$2.53B-57.11%
SHCSotera Health Company$2.61B-55.74%
EXASExact Sciences Corp$3.46B-41.41%
MTDMettler-Toledo International Inc$3.71B-37.16%
CRLCharles River Laboratories International Inc$4.74B-19.70%
RVTYRevvity Inc$4.81B-18.48%
ICLRIcon Plc$7.08B+19.84%
WATWaters Corp$9.24B+56.46%
LHLaboratory Corp Of America Holdings$10.34B+75.13%
IQVIQVIA Holdings Inc$23.33B+295.02%